SCHEMBL15943017

SCHEMBL15943017

CCCn1nnnc1-c1cc(C(=O)OC)cc(-c2ccc(C)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD11B1 P28845 2/20 0.43
HPGD P15428 1/20 0.43
TP53 P04637 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TRPV1 Q8NER1 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL357782 0.91 ALDH1A1 (0.53) ALDH1A1HSD11B1HPGDTP53TDP1
SCHEMBL3715230 0.86 ALDH1A1 (0.49) ALDH1A1HSD11B1HPGDTP53TDP1
SCHEMBL357897 0.77 DHODH (0.47) ALDH1A1HSD11B1HPGDTP53
SCHEMBL18172362 0.74 P2RX3 (0.60) ALDH1A1HPGDTP53TDP1LMNA
SCHEMBL1495498 0.74 TDP1 (0.64) ALDH1A1MEN1KMT2AHPGDTDP1
SCHEMBL356382 0.74
SCHEMBL357632 0.73 P2RX3 (0.45) ALDH1A1MEN1KMT2AHPGDTP53
SCHEMBL13415725 0.71 CNR2 (0.60) ALDH1A1MEN1KMT2AHPGDTDP1
SCHEMBL16769662 0.71 TDP1 (0.77) ALDH1A1MEN1KMT2AHPGDTDP1
SCHEMBL21241138 0.71 TDP1 (0.69) ALDH1A1MEN1KMT2AHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038264-B1 TETRAZOLE-SUBSTITUTED ARYLAMIDES HOFFMANN LA ROCHE (CH) 2016-10-26 EP disclosed
EP-2592070-B1 Tetrazole-substituted arylamides HOFFMANN LA ROCHE (CH) 2016-08-31 EP disclosed
EP-2570407-B1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2014-08-13 EP disclosed
EP-2234989-B1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2014-08-13 EP disclosed